News: "Nanosilver", Ebola drug developed by a Nigerian in diaspora, arrives today

Nigeria’s health minister Onyebuchi Chukwu has revealed that an experimental drug for the treatment of Ebola Viral Disease has been developed by a Nigerian in diaspora and is expected to arrive in the country today.
The vaccine, identified as “Nanosilver”, can now be used as a result of the approval by the World Health Organisation (WHO) that experimental treatments are ethical in the case of the Ebola pandemic.
The Nigerian federal government authorised the use of trial drugs for the affliction on Wednesday. The United States had sent ZMapp, another experimental drug, to Liberia on Wednesday, while Canada has decided to donate 1,000 vaccines to the affected countries.